@article{81aac9c727db43ba874005691bff3589,
title = "Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19",
author = "Jan Wysocki and Enrique Lores and Minghao Ye and Soler, {Maria Jose} and Daniel Batlle",
note = "Funding Information: This work was supported by the Joseph and Bessie Feinberg Foundation (Dr. Daniel Batlle). We thank Dr. Hong D. Xiao (Providence Portland Medical Center, Portland, OR) and Dr. Kenneth E. Bernstein (Cedars Sinai, Los Angeles, CA) for generously providing kidneys from ACE deficiency models. Dr. Daniel Batlle reports nonfinancial support from Angiotensin Therapeutics Inc., outside the submitted work. Dr. Maria Jose Soler reports personal fees from AstraZeneca, nonfinancial support from Boehringer In-gelheim, nonfinancial support from Eli Lilly, personal fees and nonfinancial support from Esteve, personal fees from FMC, personal fees from Janssen, personal fees from Mundi-pharma, and personal fees from NovoNordisk, outside the submitted work. Funding Information: D. Batlle was funded by National Institute of Diabetes and Digestive Kidney Diseases grant RO1DK104785.",
year = "2020",
month = sep,
doi = "10.1681/ASN.2020050667",
language = "English (US)",
volume = "31",
pages = "1941--1943",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "9",
}